Work

A Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients With Nonalcoholic Steatohepatitis

Year: 2020

Type: article

Source: Clinical Gastroenterology and Hepatology

DOI: 10.1016/j.cgh.2020.10.051

Authors: Mohammad Shadab Siddiqui, Michael O. Idowu, Deven Parmar, Brian B. Borg, Douglas Denham, Nicole M. Loo, Donald Lazas, Ziad Younes, Arun J. Sanyal

Institutions: Virginia Commonwealth University, Virginia Commonwealth University Medical Center, Clinical Trials of Texas, Texas Liver Institute, Gastro One (United States)

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, Merck, Novartis, Gilead Sciences, AbbVie, Novartis Pharmaceuticals Corporation, Novo Nordisk, Shire

OpenAlex ID: W3096860088

FWCI: 7.704

Cites: 5

Cited by: 93

Related to: 10